… MACE was strongly recommended for assessment as the safety and efficacy endpoints by
… of SSRIs on the risk of MACE in depressed patients with previous cardiovascular events. …

… in the subgroup of serotonin selective reuptake inhibitors, and for … Patients with depression
and anxiety are also more likely to … Effects of selective serotonin reuptake inhibitors on platelet …

… Senile depression patients in China usually present with a higher risk of coronary heart
disease that may trigger cardiac death. Selective serotonin reuptake inhibitors (SSRIs) were the …

… risk of coronary heart disease (CHD). It is therefore not surprising that depression is highly
comorbid with CHD, being two to three times more common among patients with CHD than in …

… Selective serotonin reuptake inhibitors appear to be safe in patients with … Selective serotonin
reuptake inhibitors may be preferred in the treatment of patients with coronary artery disease…

… Selective 5-hydroxytryptamine reuptake inhibitors (SSRIs) are the preferred antidepressants
… treatment for CHD patients with depression can be an effective and safe approach. Table 1 …

… Based upon the chronicity and high morbidity of depressive and anxiety disorders, and
the relative safety of long-term use of SSRIs, the benefits of long-term SSRI use will likely …

… used in patients with established coronary heart disease and … could be impaired by serotonin
reuptake inhibitors, leading to … good cardiovascular safety in depressed patients without …

… with coronary heart disease) have shown only small or even no effects … patients found the
selective serotonin reuptake inhibitors (SSRIs) sertraline and escitalopram safe for HF patients …

… serotonin reuptake inhibitors seem to be a safe treatment option for patients with depression
and … for reducing depression severity, morbidity, and mortality and improving quality of life in …